Charles Homcy, Former Director at Portola Pharma, holds 297.87K shares in Portola Pharma (Ticker: PTLA), holds ― shares in MyoKardia (Ticker: MYOK), holds 37.05K shares in Maze Therapeutics, Inc. (Ticker: MAZE).
Charles Homcy latest transaction was an Uninformative Buy of ―.
What was Charles Homcy's most profitable transaction?
Charles Homcy’s most profitable transaction was an Informative Sell of GBT stock on October 27, 2017. The return on the trade was -4.50%.
What is Charles Homcy's role in Portola Pharma?
Charles Homcy's role in Portola Pharma is Former Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.